Who makes PF-07261271?

PF-07261271 is developed by Pfizer Inc..

What are the side effects of PF-07261271?

Common side effects include Hepatic enzyme increased, Headache, Asthenia, Chills, Injection site pain, Contusion.

What is the generic name of PF-07261271?

pf-07261271 is the generic (nonproprietary) name of PF-07261271.

Last reviewed 2026-04-20 · How we verify

PF-07261271 (pf-07261271)

Pfizer Inc. · Phase 1 active Quality 10/100

At a glance

Generic name	pf-07261271
Sponsor	Pfizer Inc.
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Hepatic enzyme increased
Headache
Asthenia
Chills
Injection site pain
Contusion
Dry skin
Haematoma
Arrhythmia
Ventricular extrasystoles
Diarrhoea
Nausea

Key clinical trials

A Study to Learn About Study Medicine Called PF-07261271 in Healthy People (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PF-07261271 CI brief — competitive landscape report
PF-07261271 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI